UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-world treatment patterns in resectable (stages I–III) non-small-cell lung cancer: a systematic literature review

Future oncology (London, England), 2022-04, Vol.18 (12), p.1519-1530

2022

Volltextzugriff (PDF)

Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods

BJOG : an international journal of obstetrics and gynaecology, 2010-03, Vol.117 (4), p.407-415

2010

Volltextzugriff (PDF)

Payment, compensation and replacement - the ethics and motivation of blood and plasma donation

Vox sanguinis, 2010-10, Vol.99 (3), p.202-211

2010

Volltextzugriff (PDF)

Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up

Medical decision making, 2023-01, Vol.43 (1), p.91-109

2023

Volltextzugriff (PDF)

Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

ANNALS OF ONCOLOGY, 2019-04, Vol.30 (Suppl 2), p.ii16-ii17

2019

Volltextzugriff (PDF)

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

ANNALS OF ONCOLOGY, 2019-04, Vol.30 (Suppl 2), p.ii17-ii17

2019

Volltextzugriff (PDF)

Establishing the need for immuno-oncology (IO) therapy (tx) in second-line (2L) small cell lung cancer (SCLC)

Annals of oncology, 2018-10, Vol.29, p.viii430-viii431

2018

Volltextzugriff (PDF)

MA 01.09 Treatment Patterns in Extensive Disease Small Cell Lung Cancer Across the United States, Europe, and Japan

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1801-S1802

2017

Volltextzugriff (PDF)

Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

Annals of oncology, 2019-04, Vol.30, p.ii14-ii15

2019

Volltextzugriff (PDF)

Cost-effectiveness of Mandibular Two-implant Overdentures and Conventional Dentures in the Edentulous Elderly

Journal of dental research, 2005-09, Vol.84 (9), p.794-799

2005

Volltextzugriff (PDF)

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Annals of oncology, 2019-04, Vol.30, p.ii15-ii16

2019

Volltextzugriff (PDF)

Role of IncP-1β Plasmids pWDL7::rfp and pNB8c in Chloroaniline Catabolism as Determined by Genomic and Functional Analyses

Applied and Environmental Microbiology, 2012-02, Vol.78 (3), p.828-838

2012

Volltextzugriff (PDF)

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Annals of oncology, 2019-04, Vol.30, p.i38-i38

2019

Volltextzugriff (PDF)

3115 Real-world treatment patterns among patients with advanced non-small cell lung cancer in Europe: Evidence from a retrospective chart review in France, Germany, Italy and Spain

European journal of cancer (1990), 2015-09, Vol.51, p.S641-S641

2015

Volltextzugriff (PDF)

The McGill consensus statement on overdentures. Mandibular two-implant overdentures as first choice standard of care for edentulous patients. Montreal, Quebec, May 24-25, 2002

The International journal of oral and maxillofacial implants, 2002-07, Vol.17 (4), p.601

2002

Volltextzugriff (PDF)

Living with uncertainty: concept advancement

Journal of advanced nursing, 2007-03, Vol.57 (6), p.658-667

Penrod, Janice

2007

Volltextzugriff (PDF)

(233) Evaluating the agreement between self-reported and documented analgesic use in older veterans with osteoarthritis

The journal of pain, 2017-04, Vol.18 (4), p.S34-S34

2017

Volltextzugriff (PDF)

Letter to the Editor - Response to 'How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems?'- F. Rossi, R. Perry, J. de Wit,T. Evers & G. Folléa, Vox Sanguinis DOI

Vox sanguinis, 2012-04, Vol.102 (3), p.269

2012

Volltextzugriff (PDF)

Letter to the Editor - Response to 'How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems?'- F. Rossi, R. Perry, J. de Wit,T. Evers & G. Folléa, Vox Sanguinis DOI: 10.1111/j.1423-0410.2011.01495.x

Vox sanguinis, 2012-04, Vol.102 (3), p.269-270

2012

Volltextzugriff (PDF)

Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns

Annals of oncology, 2010-08, Vol.21 (8), p.1731-1732

2010

Volltextzugriff (PDF)

The McGill Consensus Statement on Overdentures. Montreal, Quebec, Canada. May 24-25, 2002

The International journal of prosthodontics, 2002-07, Vol.15 (4), p.413

2002

Volltextzugriff (PDF)

The McGill Consensus Statement on Overdentures Mandibular two-implant overdentures as first choice standard of care for edentulous patients

Gerodontology, 2002-07, Vol.19 (1), p.3-4

2002

Volltextzugriff (PDF)

The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being

Rheumatology (Oxford, England), 2005-06, Vol.44 (6), p.751-755

2005

Volltextzugriff (PDF)

10P Treatment-free survival (TFS) in metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with 1L nivolumab plus ipilimumab (NIVO+IPI) or platinum doublet chemotherapy (PDC) in CheckMate (CM) 227

Annals of oncology, 2022-04, Vol.33, p.S32-S33

2022

Volltextzugriff (PDF)

Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain: Results of A Retrospective Medical Chart Review

Value in health, 2015-11, Vol.18 (7), p.A450-A450

2015

Volltextzugriff (PDF)

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(401)
Mit Volltextzugriff
(408)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Real-world treatment patterns in resectable (stages I–III) non-small-cell lung cancer: a systematic literature review

Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods

Payment, compensation and replacement - the ethics and motivation of blood and plasma donation

Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up

Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

Establishing the need for immuno-oncology (IO) therapy (tx) in second-line (2L) small cell lung cancer (SCLC)

MA 01.09 Treatment Patterns in Extensive Disease Small Cell Lung Cancer Across the United States, Europe, and Japan

Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

Cost-effectiveness of Mandibular Two-implant Overdentures and Conventional Dentures in the Edentulous Elderly

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Role of IncP-1β Plasmids pWDL7::rfp and pNB8c in Chloroaniline Catabolism as Determined by Genomic and Functional Analyses

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

3115 Real-world treatment patterns among patients with advanced non-small cell lung cancer in Europe: Evidence from a retrospective chart review in France, Germany, Italy and Spain

The McGill consensus statement on overdentures. Mandibular two-implant overdentures as first choice standard of care for edentulous patients. Montreal, Quebec, May 24-25, 2002

Living with uncertainty: concept advancement

(233) Evaluating the agreement between self-reported and documented analgesic use in older veterans with osteoarthritis

Letter to the Editor - Response to 'How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems?'- F. Rossi, R. Perry, J. de Wit,T. Evers & G. Folléa, Vox Sanguinis DOI

Letter to the Editor - Response to 'How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems?'- F. Rossi, R. Perry, J. de Wit,T. Evers & G. Folléa, Vox Sanguinis DOI: 10.1111/j.1423-0410.2011.01495.x

Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns

The McGill Consensus Statement on Overdentures. Montreal, Quebec, Canada. May 24-25, 2002

The McGill Consensus Statement on Overdentures Mandibular two-implant overdentures as first choice standard of care for edentulous patients

The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being

10P Treatment-free survival (TFS) in metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with 1L nivolumab plus ipilimumab (NIVO+IPI) or platinum doublet chemotherapy (PDC) in CheckMate (CM) 227

Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain: Results of A Retrospective Medical Chart Review

Suchergebnisse filtern